Central administration of GLP-1-(7-36) amide inhibits food and water intake in rats.
about
Long-acting glucagon-like peptide-1 receptor agonists have direct access to and effects on pro-opiomelanocortin/cocaine- and amphetamine-stimulated transcript neurons in the mouse hypothalamusEmerging role of the brain in the homeostatic regulation of energy and glucose metabolismReview: Miglitol has potential as a therapeutic drug against obesityMoving beyond energy homeostasis: new roles for glucagon-like peptide-1 in food and drug rewardGLP-1-based strategies: a physiological analysis of differential mode of actionGLP-1, the gut-brain, and brain-periphery axesTherapy for obesity based on gastrointestinal hormonesEffects of GLP-1 on appetite and weightPhysiology of proglucagon peptides: role of glucagon and GLP-1 in health and diseaseGlucagon-Like Peptide-1 and Its Class B G Protein-Coupled Receptors: A Long March to Therapeutic SuccessesThe physiological role of the brain GLP-1 system in stressGlucagon-like peptide 1 interacts with ghrelin and leptin to regulate glucose metabolism and food intake through vagal afferent neuron signalingRole of appetite-regulating peptides in the pathophysiology of addiction: implications for pharmacotherapyThe anorectic effect of GLP-1 in rats is nutrient dependentThe glucagon-like peptide 1 analogue, exendin-4, attenuates the rewarding properties of psychostimulant drugs in miceThe glucagon-like peptide 1 receptor agonist liraglutide attenuates the reinforcing properties of alcohol in rodentsThe arcuate nucleus mediates GLP-1 receptor agonist liraglutide-dependent weight loss.Tolerability of nausea and vomiting and associations with weight loss in a randomized trial of liraglutide in obese, non-diabetic adults.Glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1: Incretin actions beyond the pancreas.Neuroimaging, gut peptides and obesity: novel studies of the neurobiology of appetite.Obesity treatment: novel peripheral targets.GIP and GLP-1, the two incretin hormones: Similarities and differencesMeal-anticipatory glucagon-like peptide-1 secretion in rats.Dissecting carboxypeptidase E: properties, functions and pathophysiological roles in disease.Roux-en-Y gastric bypass does not affect daily water intake or the drinking response to dipsogenic stimuli in ratsExendin-4 improves blood glucose control in both young and aging normal non-diabetic mice, possible contribution of beta cell independent effects.Preliminary examination of glucagon-like peptide-1 levels in women with purging disorder and bulimia nervosa.Pioglitazone and alogliptin combination therapy in type 2 diabetes: a pathophysiologically sound treatment.Dose combinations of exendin-4 and salmon calcitonin produce additive and synergistic reductions in food intake in nonhuman primatesAssociation study of 182 candidate genes in anorexia nervosaEndogenous glucagon-like peptide-1 reduces drinking behavior and is differentially engaged by water and food intakes in rats.Gut peptide GLP-1 and its analogue, Exendin-4, decrease alcohol intake and rewardExpression and distribution of glucagon-like peptide-1 receptor mRNA, protein and binding in the male nonhuman primate (Macaca mulatta) brain.The role of incretins in glucose homeostasis and diabetes treatment.Preproglucagon neurons project widely to autonomic control areas in the mouse brain.Preproglucagon (PPG) neurons innervate neurochemically identified autonomic neurons in the mouse brainstemThe glucagon-like peptide 1 analogue Exendin-4 attenuates the nicotine-induced locomotor stimulation, accumbal dopamine release, conditioned place preference as well as the expression of locomotor sensitization in mice.Obesity surgery and gut-brain communication.Pancreatic signals controlling food intake; insulin, glucagon and amylinActivation of the GLP-1 receptors in the nucleus of the solitary tract reduces food reward behavior and targets the mesolimbic system.
P2860
Q26749191-4B7627C4-EECC-4C94-87AD-6FF4A466646FQ26766494-DF3CF17B-C03B-4DFC-989B-6B18F6B49771Q26775478-1AE9892E-E860-4365-B280-46088E7F19A4Q26826926-F67FB41B-2BCC-4974-9C9B-926C30FB0C99Q26997149-E22D3E42-E9B1-43E9-B273-41BAC9D4DADFQ27000749-998D476C-5896-49D9-9CDC-2861FC603188Q27006777-0007E337-EA09-4896-BABF-AA4CDDC18E2FQ27011627-20FC4FC1-1C98-4826-A795-8A946CCFE7C8Q27027920-D1C5D6FE-90D5-4687-B35A-C4B1AF4E3072Q28067465-2364C1B9-C2D6-40E0-A7CC-67CCEC8D80F4Q28077787-00F577D7-C065-42C2-85BD-BC78500EDCFAQ28084873-6ED705D6-CEA6-4935-94E1-CC2EB8276096Q28109507-AFECED3A-60A3-461B-A546-5CA44AB22F1BQ28484398-D2F95628-A0B3-45F6-AFBE-A9B0A21C191BQ28534678-998B0937-D5E3-4367-9691-B7F9F3223DA6Q28598004-1DA8CE48-2063-4AE9-85CA-C44008B94D1DQ30596646-50D23C33-AA2D-49B3-B75E-6924844B974EQ33570118-C80DD417-9977-44B9-8C9B-4B5E7639A705Q33603384-93EF4103-BB29-4C8F-AE47-C96C1F43D614Q33606106-DF5E818E-9663-4F83-9B8F-1A9E0F813C16Q33607971-4F1F36D8-1026-41C0-8601-C5059EC04523Q33609502-7E59B07B-9437-406B-9A55-3E4BF6442F97Q33634407-BC7684C0-FAA3-4C75-AA76-C93B16DEE575Q33697577-B7F6C4EB-A906-4C2B-AE26-D53E2263452EQ33912979-0CD7EEB6-97BD-4C22-8FDE-97C10F5FE1A9Q33927198-49BA9243-FC38-45AD-BFB7-37879D4300FAQ34135563-C0022D18-404C-4EFF-B397-28FC03835CA9Q34139048-B48F652B-D6CE-4269-940F-8A5C8DA4B066Q34150227-07C56462-F0C3-4CED-AE3D-3E4B262E0F70Q34235895-1699EF42-C6D9-49D8-AAFE-3842DEFF0515Q34614609-FA6F8439-23AA-4F17-9E59-313513FD0509Q34685472-516DD862-5661-47BB-BA94-8B25DFCF75CAQ34745109-18065642-3CF4-4437-BE4D-AD454EC4EFF4Q34901533-E9371291-B868-4477-80AB-BB8F98F0F374Q34981134-AA04CEE3-D310-4454-BFE0-C78BB3183FCCQ34981138-0AA2B39F-247E-4EF8-BDBE-24F7976586E3Q35035127-C5F65AB1-B260-43DD-9173-A152FF43A64DQ35054892-951536A9-A290-4979-9BAC-104839B1CF49Q35140241-31AD23C6-C250-4763-A8A7-8BB9F3BB16ABQ35202664-6B144C26-7678-4FC7-BDFC-3D7F34372AE5
P2860
Central administration of GLP-1-(7-36) amide inhibits food and water intake in rats.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年学术文章
@wuu
1996年学术文章
@zh
1996年学术文章
@zh-cn
1996年学术文章
@zh-hans
1996年学术文章
@zh-my
1996年学术文章
@zh-sg
1996年學術文章
@yue
1996年學術文章
@zh-hant
name
Central administration of GLP-1-
@nl
Central administration of GLP-1-(7-36) amide inhibits food and water intake in rats.
@en
type
label
Central administration of GLP-1-
@nl
Central administration of GLP-1-(7-36) amide inhibits food and water intake in rats.
@en
prefLabel
Central administration of GLP-1-
@nl
Central administration of GLP-1-(7-36) amide inhibits food and water intake in rats.
@en
P2093
P1476
Central administration of GLP-1-(7-36) amide inhibits food and water intake in rats.
@en
P2093
A Fink-Jensen
D S Jessop
M Tang-Christensen
P J Larsen
S P Sheikh
P304
P356
10.1152/AJPREGU.1996.271.4.R848
P407
P433
P577
1996-10-01T00:00:00Z